Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Cutaneous graft versus host disease]

S Aractingi1, O Chosidow, E Gluckman

  • 1Clinique des Maladies cutanées, Hôpital Saint-Louis, Paris.

Presse Medicale (Paris, France : 1983)
|April 8, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phenotypical and functional characteristics of in vitro expanded bone marrow mesenchymal stem cells from patients with systemic sclerosis.

Annals of the rheumatic diseases·2007
Same author

Long-term follow-up results after autologous haematopoietic stem cell transplantation for severe systemic sclerosis.

Annals of the rheumatic diseases·2007
Same author

Long-term outcomes after allogeneic stem cell transplantation for children with hematological malignancies.

Bone marrow transplantation·2007
Same author

Combined inhaled steroids and bronchodilatators in obstructive airway disease after allogeneic stem cell transplantation.

Bone marrow transplantation·2007
Same author

Haematopoietic stem cell transplantation trends in children over the last three decades: a survey by the paediatric diseases working party of the European Group for Blood and Marrow Transplantation.

Bone marrow transplantation·2007
Same author

[Clinical research at the European LeukemiaNet].

Deutsche medizinische Wochenschrift (1946)·2006

Graft versus host disease (GVHD) is a common complication of allogeneic bone marrow transplants, caused by donor T cells attacking the recipient. GVHD presents acutely or chronically, primarily affecting the skin but also other organs.

Area of Science:

  • Immunology
  • Transplantation Medicine
  • Dermatology

Context:

  • Graft versus host disease (GVHD) is a significant complication following allogeneic bone marrow transplantation.
  • It arises from the immune response of donor T lymphocytes against recipient tissues.
  • GVHD manifests in acute and chronic forms, with distinct clinical presentations and timelines post-transplant.

Purpose:

  • To describe the clinical characteristics, risk factors, and management of graft versus host disease.
  • To differentiate between acute and chronic GVHD based on timing and manifestations.
  • To highlight the diagnostic challenges and therapeutic strategies for GVHD.

Summary:

  • GVHD results from donor T-cell activity against the recipient in allogeneic bone marrow transplants.

Related Experiment Videos

  • Acute GVHD typically presents within 3 months with a maculopapular rash, while chronic GVHD appears later with lichenoid or sclerodermal lesions.
  • Risk factors include HLA mismatch, recipient age, and T-cell dose; treatment involves corticosteroids and immunosuppressors.

    • Impact:

    • Understanding GVHD is crucial for managing post-transplant complications.
    • Accurate diagnosis and risk factor identification improve patient outcomes.
    • Effective treatment strategies mitigate GVHD-associated immune deficiency and infection risk.